June 3 2025, David R Brown
Brenntag Specialties acquires GMP value added services provider, mcePharma to serve fast growing Biopharma market
Brenntag, the global market leader in chemicals and ingredients distribution, has announced the acquisition of mcePharma a.s., Czech Republic. The acquisition of mcePharma will strengthen Brenntag's capabilities across their pharmaceutical and biopharmaceutical value chain. The existing state-of-the-art GMP facilities, advanced sampling services, and expertise in both OTC product development and GMP powder pack-off will add to the growing portfolio of capabilities and value added services Brenntag Pharma offers principals and customers in the EMEA region.
This acquisition represents a key milestone in our strategic initiatives to further expand our biopharmaceutical services
Gust Desmedt
Global President Pharma at Brenntag Specialties
The acquisition sets up the foundation for a central hub of GMP value-added services and Brenntag is also looking at additional investments in the site to expand mcePharma's capabilities in GMP blending and down-packing to include GMP biobuffers and liquid blending in order to meet the growing demand of customers and supply partners.
“The integration of GMP blending and down-packing, along with added warehouse and office space, positions us to meet growing demand while ensuring operational excellence. It's a powerful enhancement to our portfolio that reinforces our commitment to quality, speed, and customer-centric solutions,” said Joakim Rehné, President Pharma EMEA at Brenntag.
Gust Desmedt, Global President Pharma at Brenntag Specialties, noted: “This acquisition represents a key milestone in our strategic initiatives to further expand our biopharmaceutical services on top of our offering in traditional small molecules. With the added capabilities mcePharma offers, we are confident we can serve additional customers with value added services and serve the needs of our supply partners in the rapid growing Biopharma market in EMEA and globally with specialized biobuffers.”
About Brenntag
Brenntag is the global market leader in chemicals and ingredients distribution. The company holds a central role in connecting customers and suppliers of the chemical industry. Headquartered in Essen, Germany, Brenntag has more than 18,100 employees worldwide and operates a network of about 600 sites in more than 70 countries. In 2024, Brenntag generated sales of around EUR 16.2 billion. The two global divisions, Brenntag Essentials and Brenntag Specialties, provide a full-line portfolio of industrial and specialty chemicals and ingredients as well as tailor-made application, marketing and supply chain solutions, technical and formulation support, comprehensive regulatory know-how, and digital solutions for a wide range of industries.
Source(s): Brenntag Press Release
Further Information
Visit: https://www.brenntag.com